<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mercury Laboratories has filed its mandatory annual disclosure under SEBI's Large Corporate (LC) framework for FY 2024-25. The company reported NIL incremental borrowing during the year and NIL actual borrowing through debt securities. Importantly, the company clarifies that it was not identified as a Large Corporate for FY 2024-25, so the mandatory 25% borrowing-through-debt-securities requirement does not apply. No penalty is payable for the previous block (FY 2023-24 / FY 2024-25) either. The filing is signed by the Company Secretary and CFO on April 29, 2025.
This is a routine regulatory compliance filing with no material impact on the business, financials, or shareholders. There is no new borrowing, no penalty, and no change in operations — just a confirmation that SEBI's LC borrowing rules don't apply to the company.